- Home
- CNTX vs JILL Comparison
CNTX vs JILL Comparison
Compare CNTX & JILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTX | JILL |
|---|---|---|
| Founded | 2015 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 233.1M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CNTX | JILL |
|---|---|---|
| Price | $2.28 | $17.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $6.00 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 1.6M | 41.5K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 69.33 | 3.98 |
| EPS | N/A | ★ 2.05 |
| Revenue | N/A | ★ $610,857,000.00 |
| Revenue This Year | N/A | $0.10 |
| Revenue Next Year | N/A | $2.22 |
| P/E Ratio | ★ N/A | $8.49 |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $0.49 | $13.32 |
| 52 Week High | $2.85 | $23.98 |
Technical Indicators
Market Signals| Indicator | CNTX | JILL |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 65.27 |
| Support Level | $2.06 | $14.68 |
| Resistance Level | $2.58 | $18.80 |
| Average True Range (ATR) | 0.19 | 0.57 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 39.80 | 98.39 |
Price Performance
Historical ComparisonAbout CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.